Dr. Robert Krywicki

Hematology
417 W 3rd Ave, 
Albany, GA 
Clinical Trials:Currently Recruiting for 1 Trial
417 W 3rd Ave, 
Albany, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Robert Krywicki is a Hematologist in Albany, Georgia. Dr. Krywicki is rated as an Experienced provider by MediFind in the treatment of Childhood Iron Deficiency Anemia. His top areas of expertise are Essential Thrombocythemia, Richter Syndrome, Chronic B-Cell Leukemia (CBCL), and Chronic Lymphocytic Leukemia (CLL).

His clinical research consists of participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology
Licenses
Internal Medicine in GA
Hospital Affiliations
Phoebe Sumter Medical Center
Phoebe Putney Memorial Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

PHOEBE PUTNEY MEMORIAL HOSPITAL, INC.
417 W 3rd Ave, Albany, GA 31701
Other Locations
PHOEBE PUTNEY MEMORIAL HOSPITAL, INC.
126 Hwy 280 W, Americus, GA 31719

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Enrollment Status: Recruiting
Publish Date: July 03, 2024
Intervention Type: Other, Drug
Study Drug: Crizotinib
Study Phase: Phase 3
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2025
Intervention Type: Other, Procedure, Biological, Drug
Study Phase: Not Applicable
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2025
Intervention Type: Other, Drug
Study Drug: Erlotinib Hydrochloride
Study Phase: Phase 3
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 25, 2025
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Exemestane, Letrozole, Systemic Chemotherapy
Study Phase: Phase 3
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2024
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Everolimus, Exemestane, Goserelin Acetate, Letrozole, Leuprolide Acetate, Tamoxifen Citrate
Study Phase: Phase 3
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 03, 2024
Intervention Type: Drug, Other
Study Drugs: Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Paclitaxel
Study Phase: Phase 3
View 5 Less Clinical Trials
Similar Doctors
Advanced in Childhood Iron Deficiency Anemia
Dr. Sarah C. Friend
Hematology Oncology | Oncology | Hematology
Advanced in Childhood Iron Deficiency Anemia
Dr. Sarah C. Friend
Hematology Oncology | Oncology | Hematology

Phoebe Putney Memorial Hospital, Inc.

425 W 3rd Ave, Suite 50, 
Albany, GA 
 (0.1 miles away)
229-883-0717
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Sarah Friend is a Hematologist Oncology specialist and an Oncologist in Albany, Georgia. Dr. Friend is rated as a Distinguished provider by MediFind in the treatment of Childhood Iron Deficiency Anemia. Her top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Breast Cancer. Dr. Friend is currently accepting new patients.

Distinguished in Childhood Iron Deficiency Anemia
Dr. Wenhui Zhu
Hematology Oncology | Hematology | Oncology
Distinguished in Childhood Iron Deficiency Anemia
Dr. Wenhui Zhu
Hematology Oncology | Hematology | Oncology
3131 S Main St, 
Moultrie, GA 
 (38.9 miles away)
229-890-3514
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients

Wenhui Zhu is a Hematologist Oncology specialist and a Hematologist in Moultrie, Georgia. Dr. Zhu is rated as a Distinguished provider by MediFind in the treatment of Childhood Iron Deficiency Anemia. His top areas of expertise are Urachal Cancer, Childhood Iron Deficiency Anemia, Anemia, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Zhu is currently accepting new patients.

Advanced in Childhood Iron Deficiency Anemia
Dr. Brian E. Gaupp
Hematology Oncology | Hematology | Oncology
Advanced in Childhood Iron Deficiency Anemia
Dr. Brian E. Gaupp
Hematology Oncology | Hematology | Oncology
919 S Broad St, 
Thomasville, GA 
 (53.8 miles away)
229-584-5400
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Brian Gaupp is a Hematologist Oncology specialist and a Hematologist in Thomasville, Georgia. Dr. Gaupp is rated as a Distinguished provider by MediFind in the treatment of Childhood Iron Deficiency Anemia. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Childhood Iron Deficiency Anemia. Dr. Gaupp is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Krywicki's expertise for a condition
ConditionClose
      View All 47 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile